Chongqing Zhifei Biological Products Co., Ltd. (SZSE: 300122)
Health Care · Biotechnology · CN
CN¥13.90
+6.43% today · -42.2% 1Y
Chongqing Zhifei Biological Products Co., Ltd. (SZSE: 300122) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.95B and employs 6,292 people.
Over the last twelve months the share price has lost 42.2%, trading between 11.07 and 24.37.
Tweenvest scores Chongqing Zhifei Biological Products Co., Ltd. across four factors: quality 66/100, value 65/100, growth 0/100. Its strongest factor is quality.
300122 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.95B
- Revenue (TTM)
- $1.27B
- P/E
- —
- EPS
- -6.18
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- CN¥24.37
- 52-week low
- CN¥11.07
- Avg volume (3M)
- —
- Shares outstanding
- 2.39B
- Employees
- 6,292
- Next earnings
- —
About Chongqing Zhifei Biological Products Co., Ltd.
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
- ISIN
- CNE100000V20
- Founded
- 2002
- Listed since
- Sep 28, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $138.89 | -4.26% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.